相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Calculating individualized risk components using a mobile app-based risk calculator for clinical high risk of psychosis: findings from ShangHai At Risk for Psychosis (SHARP) program
TianHong Zhang et al.
PSYCHOLOGICAL MEDICINE (2021)
Broccoli sprout beverage is safe for thyroid hormonal and autoimmune status: Results of a 12-week randomized trial
Dionysios V. Chartoumpekis et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
A Strategy to Deliver Precise Oral Doses of the Glucosinolates or Isothiocyanates from Moringa oleifera Leaves for Use in Clinical Studies
Jed W. Fahey et al.
NUTRIENTS (2019)
Bioavailability of Sulforaphane Following Ingestion of Glucoraphanin-Rich Broccoli Sprout and Seed Extracts with Active Myrosinase: A Pilot Study of the Effects of Proton Pump Inhibitor Administration
Jed W. Fahey et al.
NUTRIENTS (2019)
Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis
David R. Goldsmith et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Inflammatory biomarkers in psychosis and clinical high risk populations
Shannon Delaney et al.
SCHIZOPHRENIA RESEARCH (2019)
Epigenetic modification of Nrf2 by sulforaphane increases the antioxidative and anti-inflammatory capacity in a cellular model of Alzheimer's disease
Fangfang Zhao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Sulforaphane Inhibits the Generation of Amyloid-β Oligomer and Promotes Spatial Learning and Memory in Alzheimer's Disease (PS1V97L) Transgenic Mice
Ting-Ting Hou et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Sulforaphane attenuates microglia-mediated neuronal necroptosis through down-regulation of MAPK/NF-kappa B signaling pathways in LPS-activated BV-2 microglia
Sisi Qin et al.
PHARMACOLOGICAL RESEARCH (2018)
Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation
Akiko Matsuura et al.
SCIENTIFIC REPORTS (2018)
A comparison of conversion rates, clinical profiles and predictors of outcomes in two independent samples of individuals at clinical high risk for psychosis in China
Huijun Li et al.
SCHIZOPHRENIA RESEARCH (2018)
TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia
David R. Goldsmith et al.
SCHIZOPHRENIA RESEARCH (2018)
Sulforaphane Inhibits Inflammatory Responses of Primary Human T-Cells by Increasing ROS and Depleting Glutathione
Jie Liang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Using 'WeChat' online social networking in a real-world needs analysis of family members of youths at clinical high risk of psychosis
TianHong Zhang et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2018)
Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion
T. H. Zhang et al.
EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES (2017)
Stabilized sulforaphane for clinical use: Phytochemical delivery efficiency
Jed W. Fahey et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2017)
Glutamatergic metabolites among adolescents at risk for psychosis
Caroline Demro et al.
PSYCHIATRY RESEARCH (2017)
Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study
Stefan Smesny et al.
SCHIZOPHRENIA RESEARCH (2017)
Sulforaphane reactivates cellular antioxidant defense by inducing Nrf2/ARE/Prdx6 activity during aging and oxidative stress
Eri Kubo et al.
SCIENTIFIC REPORTS (2017)
Effect of omega-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders The NEURAPRO Randomized Clinical Trial
Patrick D. McGorry et al.
JAMA PSYCHIATRY (2017)
Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project
Ricardo E. Carrion et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
D. R. Goldsmith et al.
MOLECULAR PSYCHIATRY (2016)
Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis
Maiara Zeni-Graiff et al.
SCHIZOPHRENIA RESEARCH (2016)
Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane
Li Yang et al.
SEMINARS IN ONCOLOGY (2016)
Primary prevention of psychosis through interventions in the symptomatic prodromal phase, a pragmatic Norwegian Ultra High Risk study
Inge Joa et al.
BMC PSYCHIATRY (2015)
Neuroprotective Effect of Sulforaphane against Methylglyoxal Cytotoxicity
Cristina Angeloni et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
Perinatal Risks and Childhood Premorbid Indicators of Later Psychosis: Next Steps for Early Psychosocial Interventions
Cindy H. Liu et al.
SCHIZOPHRENIA BULLETIN (2015)
Neuroprotective Effects of Sulforaphane on Cholinergic Neurons in Mice with Alzheimer's Disease-Like Lesions
Rui Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Family-Focused Treatment for Adolescents and Young Adults at High Risk for Psychosis: Results of a Randomized Trial
David J. Miklowitz et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2014)
Sulforaphane treatment of autism spectrum disorder (ASD)
Kanwaljit Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Meta-Analysis of Oxidative Stress in Schizophrenia
Joshua Flatow et al.
BIOLOGICAL PSYCHIATRY (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome
Patrick D. McGorry et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Sulforaphane is not an effective antagonist of the human pregnane X-receptor in vivo
Emma Jane Poulton et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
The Psychosis High-Risk State A Comprehensive State-of-the-Art Review
Paolo Fusar-Poli et al.
JAMA PSYCHIATRY (2013)
Natural sulforaphane as a functional chemopreventive agent: including a review of isolation, purification and analysis methods
Hao Liang et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2012)
Early and broadly defined psychosis risk mental states
Matcheri S. Keshavan et al.
SCHIZOPHRENIA RESEARCH (2011)
Effects of Aripiprazole on Insight and Subjective Experience in Individuals With an At-Risk Mental State
Hiroyuki Kobayashi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
The MATRICS consensus cognitive battery, part 2: Co-norming and standardization
Robert S. Kern et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
The MATRICS consensus cognitive battery, part 1: Test selection, reliability, and validity
Keith H. Nuechterlein et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Evaluation of the safety and bioactivity of purified and semi-purified glucoraphanin
R. H. Lai et al.
FOOD AND CHEMICAL TOXICOLOGY (2008)
Bioavailability and Kinetics of Sulforaphane in Humans after Consumption of Cooked versus Raw Broccoli
Martijn Vermeulen et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)
The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder
Matthew J. Byerly et al.
SCHIZOPHRENIA RESEARCH (2008)
Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: A clinical phase I study
Theresa A. Shapiro et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2006)
Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline
RD Reddy et al.
SCHIZOPHRENIA BULLETIN (2004)
Interview for prodromal syndromes and the scale of prodromal symptoms: Predictive validity, interrater reliability, and training to reliability
TJ Miller et al.
SCHIZOPHRENIA BULLETIN (2003)
Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: Preliminary evidence of interrater reliability and predictive validity
TJ Miller et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)